Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard R Winkelmann

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Biomarkers in Medicine|April 22, 2010
Smoking and atherosclerotic cardiovascular disease: part IV: genetic markers associated with smokingBernhard R Winkelmann, Klaus von Holt, Martin Unverdorben
Frontiers in Endocrinology|March 6, 2024
Whole-exome sequencing in familial type 2 diabetes identifies an atypical missense variant in the RyR2 geneVikas Bansal, Bernhard R Winkelmann, Johannes W Dietrich, et al.
The American Journal of Cardiology|July 31, 2003
Effects of statins on C-reactive protein and interleukin-6 (the Ludwigshafen Risk and Cardiovascular Health study)Winfried März, Karl Winkler, Markus Nauck, et al.
European Heart Journal|December 2, 2004
The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)Winfried März, Hubert Scharnagl, Michael M Hoffmann, et al.
Diabetes Care|April 26, 2011
Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiographyGuenther Silbernagel, Tanja B Grammer, Bernhard R Winkelmann, et al.
Clinical Chemistry|April 28, 2009
Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health studyTanja B Grammer, Dietmar Fuchs, Bernhard O Boehm, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 8, 2007
Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusionTatjana Stojakovic, Hubert Scharnagl, Winfried März, et al.
The American Journal of Cardiology|November 27, 2002
C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) studyMarkus Nauck, Bernhard R Winkelmann, Michael M Hoffmann, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 20, 2002
The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarctionMarkus Nauck, Bernhard R Winkelmann, Michael M Hoffmann, et al.
Atherosclerosis|August 16, 2006
G-protein beta3 subunit (GNB3) gene polymorphisms and cardiovascular disease: the Ludwigshafen Risk and Cardiovascular Health (LURIC) studyWilfried Renner, Michael M Hoffmann, Gerda Grünbacher, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Biomarkers in Medicine|April 22, 2010
Smoking and atherosclerotic cardiovascular disease: part IV: genetic markers associated with smokingBernhard R Winkelmann, Klaus von Holt, Martin Unverdorben
Frontiers in Endocrinology|March 6, 2024
Whole-exome sequencing in familial type 2 diabetes identifies an atypical missense variant in the RyR2 geneVikas Bansal, Bernhard R Winkelmann, Johannes W Dietrich, et al.
The American Journal of Cardiology|July 31, 2003
Effects of statins on C-reactive protein and interleukin-6 (the Ludwigshafen Risk and Cardiovascular Health study)Winfried März, Karl Winkler, Markus Nauck, et al.
European Heart Journal|December 2, 2004
The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)Winfried März, Hubert Scharnagl, Michael M Hoffmann, et al.
Diabetes Care|April 26, 2011
Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiographyGuenther Silbernagel, Tanja B Grammer, Bernhard R Winkelmann, et al.
Clinical Chemistry|April 28, 2009
Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health studyTanja B Grammer, Dietmar Fuchs, Bernhard O Boehm, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 8, 2007
Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusionTatjana Stojakovic, Hubert Scharnagl, Winfried März, et al.
The American Journal of Cardiology|November 27, 2002
C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) studyMarkus Nauck, Bernhard R Winkelmann, Michael M Hoffmann, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 20, 2002
The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarctionMarkus Nauck, Bernhard R Winkelmann, Michael M Hoffmann, et al.
Atherosclerosis|August 16, 2006
G-protein beta3 subunit (GNB3) gene polymorphisms and cardiovascular disease: the Ludwigshafen Risk and Cardiovascular Health (LURIC) studyWilfried Renner, Michael M Hoffmann, Gerda Grünbacher, et al.
Pageof 8